About Mercy Medical Center - The Institute for Digestive Health and Liver Disease
"From more common digestive tract diagnoses such as heartburn and colorectal disease to complex diagnoses for liver cancer and pancreatic cancer, Mercy Medical Center and The Institute for Digestive Health & Liver Disease offer patients a comprehensive and coordinated approach, aiming to continue to be one of the best Gastroenterology Centers in Baltimore and the Mid-Atlantic region. The dedicated physician team works to provide the best treatment options available for digestive disorders. The Center's top specialists provide advanced therapies, education and surgical treatment options that are ranked among the best available in the United States. Academic and research leadership drives our doctors to actively participate in research and c"
Clinical Trials at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
During the past decade, Mercy Medical Center - The Institute for Digestive Health and Liver Disease conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
According to Clinical.Site data, the most researched conditions in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are
"NASH - Nonalcoholic Steatohepatitis" (2 trials), "Biliary Cirrhosis, Primary" (1 trials), "Cirrhosis" (1 trials), "Hepatocellular Cancer" (1 trials) and "Prevention of Esophageal Varices" (1 trials). Many other conditions were trialed in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Most popular intervention types in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "HM15211" (1 trials), "Placebo" (1 trials), "Placebo of HM15211" (1 trials) and "belapectin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
The vast majority of trials in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are
4 trials for "All" genders.
Clinical Trials Status at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Currently, there are NaN active trials in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mercy Medical Center - The Institute for Digestive Health and Liver Disease,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Medical Center - The Institute for Digestive Health and Liver Disease, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".